Comparison of Laparoscopic Surgery and Open Surgery for Repair of Gastric Perforation
1 other identifier
observational
827
0 countries
N/A
Brief Summary
Gastric perforation (GP) is a penetrating lesion of the gastric wall that accounts for 10-15% of all peptic ulcer perforations, and most GP are spontaneous perforations caused by ulcer disease. Due to the presence of gastric acid, most patients often present to the emergency department with severe abdominal or chest pain due to chemical peritonitis within a few hours of perforation. Emergency physicians often quickly diagnose GP by using a chest x-ray or CT in an upright position and the patient's symptoms. Studies have shown that about 80-85% of patients with GP had subphrenic free gas visible on x-ray in the upright position. Surgery is currently the mainstay of treatment for most GP, and almost all cases require urgent surgical repair.2 Over the past few years, laparoscopic surgery has become increasingly popular in clinical practice due to its advantages of less pain, less scarring, and early mobility out of bed, and has become the standard treatment for many elective and emergency procedures. Since the laparoscopic study of PPU was first published by Mouret P in 1990, investigators have launched extensive discussions on the effects of laparoscopic surgery and open surgery in patients with perforated ulcers. However, to our knowledge, there are few separate discussions on GP, and the postoperative prognosis of laparoscopic surgery for patients with GP is less clear. Therefore, the aim of this multicenter, large-scale retrospective study was to compare the clinical outcomes of laparoscopic surgery and open surgery in patients with GP, to investigate whether laparoscopic surgery is safe and feasible for patients with GP, and to provide reliable evidence for surgical strategies in patients with GP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 6, 2025
CompletedFirst Posted
Study publicly available on registry
March 11, 2025
CompletedMarch 11, 2025
March 1, 2025
10.9 years
March 6, 2025
March 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
overall survival
Overall survival (OS) was described as time from date of diagnosis until the date of death from any cause or or loss to follow-up.
From date of diagnosis until the date of death from any cause or or loss to follow-up, whichever came first, assessed up to 60 months.
Study Arms (1)
the gastric perforation group
patients diagnosed as gastric perforation
Interventions
Open surgery was performed in patients undergoing gastric perforation
Laparoscopic surgery was performed in patients undergoing gastric perforation
Eligibility Criteria
patients diagnosed with gastric perforation
You may qualify if:
- age ≥18 years;
- patients diagnosed with gastric perforation.
You may not qualify if:
- patients with incomplete clinical data;
- laparoscopic surgery transfer to open surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dong Penglead
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 6, 2025
First Posted
March 11, 2025
Study Start
January 1, 2013
Primary Completion
December 1, 2023
Study Completion
January 1, 2024
Last Updated
March 11, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
Clinical centres conducting this study are not allowed to disclose patient information and data sharing.